Share Buyback In H. Lundbeck A/S

Valby, Denmark, Jan 24, 2008 - (ABN Newswire) - Acting on its authorization to acquire up to 10% of its shares, Lundbeck's Supervisory Board has resolved to initiate a share buyback program. Under the program Lundbeck will buy own shares for an amount of up to DKK 6 billion, cf. stock exchange announcement number 166 dated 17 August 2005. The buyback program is expected to be completed by the end of 2008.

During any one single trading day a maximum of 25% of the average daily trading volume of Lundbeck shares on OMX Nordic Exchange Copenhagen, calculated over 20 days prior to each trading date, will be bought back, as the share buyback program is implemented in accordance with the provisions of the European Commission's regulation no. 2273/2003 of December 22, 2003.

At least once every seven trading days, Lundbeck will issue an announcement in respect of the transactions made under the program.

The following transactions have been made under the program:

No. of shares Average Transaction value purchase price (DKK) (DKK) Accumulated, last 26,280,134 135.8874 3,573,241,523 announcement 15 January 2008 95,000 136.5512 12,972,362.94 16 January 2008 97,300 130.7085 12,717,936.79 17 January 2008 100,000 129.9249 12,992,493.00 18 January 2008 97,400 126.2309 12,294,894.38 21 January 2008 104,000 116.6083 12,127,260.60 22 January 2008 105,800 114.8125 12,147,161.55 23 January 2008 104,500 113.4497 11,855,494.79 Accumulated under the 26,984,134 135.6482 3,660,349,127 program

Following the above buyback it is hereby announced that Lundbeck owns a total of 7,827,347 own shares at a nominal value of DKK 5, equal to 3.78% of the total number of 207,279,631 shares.

The content of this release will have no influence on the Lundbeck Group's financial results for the 2007 financial year, due to be announced on 4 March 2008. On the same occasion, Lundbeck will present its financial guidance for 2008.

Lundbeck contacts

Investors: Media:

Jacob Tolstrup Anders Schroll Director, Corporate Reporting Head of Communication +45 36 43 30 79 +45 36 43 20 81

Palle Holm Olesen Head of Investor Relations +45 36 43 24 26
________________________

Stock Exchange Release No 321 - 23 January 2008

About Lundbeck H. Lundbeck A/S is an international pharmaceutical company engaged in the research and development, production, marketing and sale of drugs for the treatment of psychiatric and neurological disorders. In 2006, the company's revenue was DKK 9.2 billion (approximately EUR 1.2 billion or USD 1.6 billion). The number of employees is approximately 5,300 globally. For further information, please visit www.lundbeck.com



LINK: http://hugin.info/130085/R/1184648/236850.pdf Copyright © Hugin AS 2008. All rights reserved.

H. Lundbeck

http://www.lundbeck.com

ISIN: DK0010287234

Stock Identifier: XCSE.LUN